CEO Pavan Cheruvu (Sio Gene Therapies)

'We're not a van­t': Ax­o­vant seeks to for­get the past as the com­pa­ny re­brands to Sio Gene Ther­a­pies

Aim­ing to shed the lega­cy of an epic Alzheimer’s fail a few years ago, Ax­o­vant $AXGT is chang­ing its name in a full cor­po­rate …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.